Is the pyrimidine the proton-handling element of the genetic alphabet? A quantum-chemical test of a proton-centred account of infectious disease

Life is often described in terms of the large and the complex: the bacteria that invade us, the genes that carry our instructions, and the proteins that build our bodies. We speak of pathogens and receptors, of enzymes and immune responses. Yet, beneath this familiar vocabulary of organisms and molecules lies a quieter, more fundamental reality. Every interaction that defines an infection, every signal that passes between cells, is ultimately executed by two tiny things: electrons shifting their positions within atoms, and protons moving from one spot to another. While the electron is the currency of chemical bonds, the proton—the nucleus of a hydrogen atom—is the currency of energy and information. In the context of our genetic code, the way a molecule holds or releases a proton determines how it pairs with its partner, and whether the genetic message is copied correctly or corrupted.

For decades, this proton-level view has been a background detail, a footnote to the main story of biology. But a new line of inquiry suggests that the proton might be the main character after all. A specific theory proposes that infectious disease is not just a battle of organisms, but a disruption of how protons are handled at the most basic level of our genetic alphabet. This theory makes a bold claim: that the pyrimidines, one of the two families of chemical bases that make up DNA and RNA, are the primary players in this drama, more so than their cousins, the purines. The theory suggests that the ability of these molecules to grab, hold, or release a proton is the key to understanding how infections take hold and how drugs might stop them. The question is whether this idea is a useful map of reality or merely an interesting guess.

To find out, a researcher at Banaras Hindu University took this qualitative theory and subjected it to the rigorous test of modern computer simulation. The goal was not to argue about the theory in words, but to translate its claims into three specific, testable predictions and then run the numbers. The study focused on the genetic bases themselves—the pyrimidines and purines—and asked three questions. First, if pyrimidines are the proton-handling experts, do they hold onto protons more tightly than purines? Second, do successful drugs that work by confusing these bases show a specific change in how easily they switch between different shapes? And third, is the pyrimidine ring chemically more flexible and less rigidly stable than the purine ring, allowing it to respond to changes in proton position?

The first test was a direct check on the idea that pyrimidines are the superior proton grabbers. The researchers calculated how much energy it takes to attach a proton to each of the five natural genetic bases. The results were clear and contrary to the original theory. The purines, the other family of bases, actually held onto protons more tightly, with an average energy requirement of 945 kilojoules per mole, compared to 885 for the pyrimidines. The theory that pyrimidines are the "decisive participants" because they are more eager to grab a proton was proven wrong. However, the data revealed a different, more subtle truth. While the purines were all very similar to one another in how they held protons, the pyrimidines were highly varied. The difference in proton-holding strength between the different pyrimidines was nearly nine times larger than the difference between the purines. The researchers realized that the value of the pyrimidines might not be in how strongly they hold a proton, but in how distinctly different they are from one another. This variation allows the genetic code to be read with precision, whereas the purines are too uniform to provide such fine-grained information. The original idea was discarded, but a new, more interesting one emerged from the same data.

The second test looked at the mechanism of a known drug called molnupiravir, which is used to treat viral infections. This drug works by mimicking a natural base but with a twist: it can easily switch between two different shapes, or tautomers, causing the virus to make mistakes when copying its genetic code. The theory predicted that a successful drug should have a very small energy gap between its main shape and its confusing shape, making the switch easy. The computer simulations confirmed this perfectly. For a standard, inactive base, the energy gap was large, keeping the molecule locked in its correct shape. But for the active part of molnupiravir, the gap shrank dramatically, even flipping so that the confusing shape became the preferred one. The simulation predicted this shift with an accuracy of 38 kilojoules per mole without any prior tuning. This result was a strong confirmation that the theory's focus on proton position and shape-shifting is chemically sound and can predict how a drug will behave.

The third test examined the structural stability of the rings that form these bases. The theory suggested that the pyrimidine ring should be less rigidly stable than the purine ring, making it easier to distort when a proton moves. The researchers calculated the resonance energy, a measure of how much extra stability a ring gains from its electrons being shared around the circle. The results showed that the pyrimidine ring indeed has less of this stabilizing energy than the imidazole ring found in purines. It is less tightly held together, which aligns with the idea that it is more responsive to changes in proton position. This part of the theory survived the test unchanged.

The study also took a moment to check the language the theory used to describe electrons. The theory relied on a concept called hybridization, which describes how atomic orbitals mix to form bonds. The researchers tested this on a molecule known to break the rules of simple hybridization, sulfur hexafluoride. The simulation showed that the theory's description of electron behavior failed in this extreme case, revealing that the language of hybridization is not universal. However, the researchers concluded that for the carbon, nitrogen, and oxygen atoms that make up life, the language remains accurate and useful.

The paper concludes by using these findings to propose new candidates for drugs. Based on the successful prediction for molnupiravir, the researchers identified a new chemical structure that should be even more effective at confusing the genetic code, and another that should be ineffective. They did not test these in a lab or on patients; they simply calculated the energy differences. The study makes it clear that while the chemical rules they tested hold up, the broader claims about how this explains the entire course of an infection remain unproven. The clinical success of the theory is still an open question. What the study has achieved is a rare feat: it took a sweeping, qualitative idea about disease and infection, broke it down into hard numbers, and found that two of its three core chemical claims were correct, while one was wrong but led to a better understanding. It showed that the pyrimidines are not the strongest proton holders, but they are the most distinct, and that the ability to shift shapes is indeed the key to how certain drugs work. The framework is no longer just a story; it is a set of rules that can be tested, refined, and used to design the next generation of medicines.